(Total Views: 348)
Posted On: 04/13/2019 2:49:28 PM
Post# of 154975
I just read , about 101,000 new patients diagnosed every year with colon cancer in USA,
44,000 patients with rectal cancer ,
So total new patients every year with colorectal cancer in USA only, over 140,000 .
With metastatic colon cancer on chemotherapy many patients survive about 4-5 years , which mean many of those patients will be added to treatment..
And this is only USA , I believe Dr Pestell said at one point that close or above 50% patients might be good candidate for Leronlimab.
We also know that chemotherapy increase expression of CCR5 .
44,000 patients with rectal cancer ,
So total new patients every year with colorectal cancer in USA only, over 140,000 .
With metastatic colon cancer on chemotherapy many patients survive about 4-5 years , which mean many of those patients will be added to treatment..
And this is only USA , I believe Dr Pestell said at one point that close or above 50% patients might be good candidate for Leronlimab.
We also know that chemotherapy increase expression of CCR5 .
(0)
(0)
